Rifaximin to prevent diarrhea during radiation for pelvic cancer
Treatments studied
Part of Cancer, Digestive system, Kidney & urinary clinical trials.
This trial tests if adding the drug Rifaximin can help prevent diarrhea caused by radiation therapy for pelvic cancers. It may be an option for people starting radiation or chemoradiation for non-metastatic pelvic cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have pelvic cancer that has not spread to other parts of the body.
- You will be receiving radiation therapy aimed at curing your cancer, with or without chemotherapy.
- You have not had any part of your intestine surgically removed.
- You do not have irritable bowel syndrome or inflammatory bowel disease.
- You are not currently taking any anti-diarrhea medications, and you do not have diarrhea right now.
- You are not HIV positive, not taking immunosuppressive drugs, and not pregnant or breastfeeding.
- You are not allergic to rifamycin (the drug class of Rifaximin).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether rifaximin, an antibiotic that works in the gut, can reduce bloating in people with irritable bowel syndrome, constipation, or functional bloating. Rifaximin may help by changing the balance of bacteria in your intestines.
This trial tests whether a Bergmann enema can help prevent radiation-related rectal injury during short-course radiotherapy for rectal cancer. It may be an option for people who are about to start pelvic radiation.
This study tests whether a daily drink can help reduce bowel side effects caused by radiation for prostate cancer. If you are about to start radiation for intermediate to high-risk prostate cancer, you may be able to join.
This study tests if a traditional Chinese medicine formula (Gegen Qinlian Tang) plus probiotics can help people who have gut problems from radiation treatment for cancer. It may reduce diarrhea, pain, or other bowel symptoms caused by radiation.
This trial tests whether a steroid enema (dexamethasone) can help prevent or reduce bowel damage caused by radiation therapy for rectal cancer. If you're starting or recently started radiation for rectal cancer, this may help protect your bowel health.
This trial tests if adding the gut antibiotic rifaximin to ticagrelor (a blood thinner) can further reduce the risk of blood clots in people who've had a heart attack. It's for patients whose platelets are still too active despite taking ticagrelor.
Hear when a new Acute Radiation Enteritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.